SNDX EBITDA
Syndax Pharmaceuticals Inc · EBITDA
SNDX EBITDA
Latest reported-$135.24Mperiod ending
SNDX EBITDA (-$11.05M → -$135.24M)
Annual EBITDA
High-resolution chart · PNG
SNDX ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -251,631,000 | |
| -313,821,000 | |
| -209,140,000 | |
| -146,168,000 | |
| 26,868,000 | |
| -70,712,000 | |
| -55,955,000 | |
| -73,883,000 | |
| -61,878,000 | |
| -43,677,000 | |
| -20,492,000 | |
| -21,317,000 | |
| -8,558,000 | |
| -5,258,000 | |
| -11,052,000 |